Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4764577

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1noc(-c2cnn(-c3ccc(NC(=O)c4ccc([N+](=O)[O-])cc4)cc3)c2C(F)(F)F)n1

Basic Information

ChEMBL ID CHEMBL4764577
Phase Preclinical
Structure Type MOL
InChI Key RSCBIRYODPHUBV-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

458.4
MW (Da)
4.41
ALogP
8
HBA
1
HBD
129.0
PSA (Ų)
0.35
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C20H13F3N6O4
MW 458.36
Aromatic Rings 4
Heavy Atoms 33
NP-Likeness -2.27

Activity Summary

IC50 1 meas. best 5.26

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.26 5.26 5500.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 5500.0 nM 5.26 Inhibition of SOCE channel in tBhQ-treated HEK cells assessed as reduction in ca... 33854704

Literature References

PubMed DOI Target Context # Activities
33854704 10.1021/acsmedchemlett.1c00034 Unchecked 3
33854704 10.1021/acsmedchemlett.1c00034 ADMET 1

Data from ChEMBL 36 via Core Engine